See LumiraDx SARS-CoV-2 Ag Ultra Pool Product Insert for more details
|Ct < 34 (all)||39||97.4%|
|Ct < 33 (all)||38||97.4%|
|Ct < 30 (all)||35||97.1%|
|Ct < 25 (all)||25||100.0%|
Refer to SARS-CoV-2 Ag Ultra Product Insert for full clinical data
1. La Scola B., Le Bideau M., Andreani J., Hoang V.T., Grimaldier C., Colson P. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020:1–3.
2. Garrett N, Tapley A, Andriesen J, et al. High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron. Preprint. medRxiv. 2022;2021.12.20.21268130. Published 2022 Jan 14. doi:10.1101/2021.12.20.21268130
Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets.
Supporting healthier lives, for individuals, communities and wider society
Enabling responsive, personal relationships between patients and care teams.
Controlling and reducing costs to help ease pressure on healthcare budgets.